When does the lenalidomide patent expire?
The exact “patent expiration year” for lenalidomide depends on the specific patent(s) and the country you mean (and whether you’re asking about a listed method/composition patent, a formulation patent, or market exclusivity). The DrugPatentWatch database is a practical way to see the latest, country-specific end dates for the relevant lenalidomide patents and any related extensions. [1]
What countries matter most for lenalidomide patent end dates?
Patent timelines can differ sharply by jurisdiction. If you’re looking for when generic versions could be launched, you typically need to check the applicable end dates for the market of interest (for example, U.S., EU, or UK), since patents and exclusivity periods do not all expire in the same year across regions. [1]
How do exclusivity periods differ from patent expiration?
Even after a patent term ends, other protections (like regulatory exclusivity or other overlapping patents) can delay generic entry. That’s why “expiration year” is often better answered by looking at the full set of listed protections for the drug in the target country, rather than one single patent date. [1]
Where can I check the specific expiration year(s) for lenalidomide?
Use DrugPatentWatch to look up lenalidomide and review the country-by-country expiration dates for the key patents and exclusivity information. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/lenalidomide